Journal of Medicinal Chemistry p. 4401 - 4410 (2019)
Update date:2022-08-05
Topics:
Riggs, Jennifer R.
Elsner, Jan
Cashion, Dan
Robinson, Dale
Tehrani, Lida
Nagy, Mark
Fultz, Kimberly E.
Krishna Narla, Rama
Peng, Xiaohui
Tran, Tam
Kulkarni, Ashutosh
Bahmanyar, Sogole
Condroski, Kevin
Pagarigan, Barbra
Fenalti, Gustavo
Lebrun, Laurie
Leftheris, Katerina
Zhu, Dan
Boylan, John F.
Triple negative breast cancer (TNBC) is an aggressive disease with high relapse rates and few treatment options. Outlined in previous publications, we identified a series of potent, dual TTK/CLK2 inhibitors with strong efficacy in TNBC xenograft models. P
View MoreImprove Medical Technology(Nanxiong) Co., Ltd
Contact:86-751-3836997
Address:No.33, Pingan First Road, Fine Chemical Industry Base, Nanxiong City, Shaoguan, Guangdong, China
Chuzhou Baiao Biologhy S&T Co., Ltd.
Contact:+86-25-83212599;+86-25-83212699 13705185959
Address:Room 905, Tianzheng International Platza, No.399, Zhongyang Road ,Nanjing, Jiangsu Province, China
Contact:0086 371 65711996
Address:Jalan 4/3, Kawasan Perindustrian Serendah, 48000 Rawang,
website:http://www.mingchem.com/en/index
Contact:0519-85170101-802
Address:Fifth Floor,B of Beihua Buliding,520 Road of Science and Education City,Changwu middle road NO.801,Wujin District,Changzhou,Jiangsu province
CHANGZHOU HANGYU PHARMACEUTICAL TECHNOLOGY CO., LTD
website:http://www.czyys.com
Contact:0086-519-88802789
Address:No.300,Yanling Middle Road, Changzhou, Jiangsu, China
Doi:10.1021/ol503655a
(2015)Doi:10.3987/com-02-9607
(2003)Doi:10.1016/S0022-328X(00)83682-7
(1974)Doi:10.1248/cpb.22.2004
(1974)Doi:10.1021/jo00896a027
(1975)Doi:10.1021/ja01559a069
(1957)